Custom Index Systems’s Vertex Pharmaceuticals VRTX Stock Holding History

Custom Index Systems’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$401K	Buy	807 +6	+0.7%	+$2.66K	0.14%	173
2026 Q1	$358K	Buy	801 +251	+46%	+$117K	0.16%	182
2025 Q4	$249K	Hold	550	–	–	0.11%	214
2025 Q3	$215K	Hold	550	–	–	0.06%	253
2025 Q2	$245K	Sell	550 -77	-12%	-$35.5K	0.12%	217
2025 Q1	$304K	Sell	627 -591	-49%	-$275K	0.15%	201
2024 Q4	$490K	Sell	1,218 -16	-1%	-$7.42K	0.26%	101
2024 Q3	$574K	Sell	1,234 -123	-9%	-$59.1K	0.31%	94
2024 Q2	$636K	Buy	1,357 +96	+8%	+$41.7K	0.37%	59
2024 Q1	$527K	Sell	1,261 -446	-26%	-$189K	0.3%	77
2023 Q4	$695K	Buy	+1,707	New	+$631K	0.43%	51

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Custom Index Systems's VRTX Position: Q2 2026 in Review

Custom Index Systems increased its Vertex Pharmaceuticals (VRTX) stake by 0.75% in Q2 2026, buying an estimated $2.66K and bringing the position to 807 shares worth $401K. The position accounts for 0.14% of the portfolio, ranked #173.

Custom Index Systems first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $695K in Q4 2023. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Custom Index Systems held 807 shares of Vertex Pharmaceuticals worth $401K as of Q2 2026.
Custom Index Systems bought 6 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.66K.
Vertex Pharmaceuticals made up 0.14% of Custom Index Systems's portfolio in Q2 2026, its #173 holding.
Custom Index Systems first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Custom Index Systems's Vertex Pharmaceuticals position peaked at $695K in Q4 2023.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Custom Index Systems's 13F filing for Q2 2026, filed 14 Aug 2026.